2015
DOI: 10.1016/j.clim.2015.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular disease biomarkers across autoimmune diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 53 publications
0
13
0
Order By: Relevance
“…In addition to traditional cardiovascular risk factors, prolonged steroid therapy, chronicity and activity of disease, and postmenopausal status appear to raise risk specifically in CTD patients 31 32 . Many pathogenic mechanisms for increased atherosclerosis are possible in patients with CTD and likely overlap with the pathophysiology of the specific CTD itself; these include systemic inflammatory responses, autoantibody and immune complex mediated processes, and increased inflammatory cytokines from activated T cells both systemically and locally at the atheroma 33 . Some of these mechanisms, along with secondary increases in sympathetic tone, may also account for other clinical important cardiovascular outcomes in CTD patients, including heart failure and arrhythmia 15 16 17 34 .…”
Section: Discussionmentioning
confidence: 99%
“…In addition to traditional cardiovascular risk factors, prolonged steroid therapy, chronicity and activity of disease, and postmenopausal status appear to raise risk specifically in CTD patients 31 32 . Many pathogenic mechanisms for increased atherosclerosis are possible in patients with CTD and likely overlap with the pathophysiology of the specific CTD itself; these include systemic inflammatory responses, autoantibody and immune complex mediated processes, and increased inflammatory cytokines from activated T cells both systemically and locally at the atheroma 33 . Some of these mechanisms, along with secondary increases in sympathetic tone, may also account for other clinical important cardiovascular outcomes in CTD patients, including heart failure and arrhythmia 15 16 17 34 .…”
Section: Discussionmentioning
confidence: 99%
“…Cardiovascular diseases related to stroke and coronary heart disease are increasingly recognized as leading causes of premature mortality. Hence, therapeutic intervention and early prevention are urgently needed to address this issue [33] . In the diabetic mouse myocardium, 45 circRNAs were found to be increased, while 31 were decreased.…”
Section: Circrnas In Cardiovascular Dis-easesmentioning
confidence: 99%
“…[8] Endothelial cells are also of interest because dysfunction of these cells is more common in those with autoimmune disease, causing accelerated atherosclerosis and other cardiovascular disease, making it a leading cause of mortality among patients, especially in rheumatic autoimmune diseases. [9][10][11] In this study, DNA methylation and gene expression changes were characterized in human umbilical vein endothelial cell (HUVEC) primary cell lines before and after treatment with TNFα in order to help identify new therapeutic targets and to provide information that can be used to help predict possible side effects. A systems biology approach, weighted gene coexpression network analysis (WGCNA), was used to construct a gene expression network and find groups of genes that not only have a high correlation of expression but high topological overlap, meaning that to be considered members of the same group, genes need to show similar correlation patterns to other genes outside of the group.…”
Section: Introductionmentioning
confidence: 99%